It's adjusted for splits. Basically when InVivo was founded they set an arbitrary value per share of $0.01 and on a split adjusted basis it was trading at $60.

Basically what that's saying is when InVivo was founded the market cap was <$100,000 (remember when a company is first formed there are no assets) and when Frank left it was $400M.

Careers:

Frank Reynolds is doing it again:

Frank Reynolds Corp.

Everything signed and dated 8/21/2013 (the day before the announcement of his resignation).

https://www.sos.nh.gov/corporate/soskb/Corp.asp?1203151

484-919-6424

freynolds@sloan.mit.edu

89 Lake Shore Rd., Salem, New Hampshire 03079

I was concerned about the Nick Hodge pump, but it appears that there is genuine interest in the stock. I haven't found any other newsletters or pumpers publishing on KLH recently.

I would like to see a nice consolidation form @ these levels and then we could easily see a breakout past ATHs. Very exciting.

I've been holding this stock for a while and it is paying off quite nicely now! With some solid consolidation at these levels we could see a breakout to ATHs soon!

There is no doubt that Frank's TV/PR campaign with promises of FDA approval to begin trial in August/Sept combined with the company's increasing burn rate (his salary being a HUGE contributing factor) has cost investors to lose confidence and patience.

From a technical perspective there is not much support until the $1 level. Very bad looking chart at this point. RSI is very low so a bounce should be near, but the relentless selling is a BIG worry.

Good question. Likely won't work that well.

InVivo's IP doesn't prevent anyone from trying to use stem cells to treat acute or chronic SCI, however, based on InVivo's research simply injecting stem cells into the spinal cord does not result in functional recovery. This is due to the fact that the cells do not have the proper environment for attachment and growth (i.e scaffold technology).

Thus InVivo scaffold/hydrogel + stem cells is the ultimate solution. So they've cornered the market, so to speak, on the delivery mechanism.

Seel where are you getting your information on an "FDA inspection" of the facilities.

I haven't seen this mentioned anywhere. Thanks.

Indeed, that key $1.95 level might hold by the close which will put in a massive bullish hammer candle which will indicate a bottom.

Bids have firmed up at the $1.70 level (30,000 shares) and now at $1.80 (10,000 shares)

This will be a very high volume day and should wake up the NVIV management.

Someone or multiple people are relentlessly hitting the bid and the bid support is very thin and disappearing quickly.

Very reckless panicking in my opinion, but facts are facts and with little bid support we could see $1.50 today.

Maybe so, but since we broke below the coiled triangle at the $2.40 level and below the key 200 day moving average the share price has been in free fall. Now we just broke below key support levels at $1.95 and $1.80.

I think this is WAY oversold and from a technical perspective is now a HUGE buy at these levels. Easily pop to $2 on technicals alone.

Absolutely needs to hold the $1.95 level and preferably close above $2.00 or else the technical picture looks absolutely horrible.

For every buyer there is a seller. That's basic.

Someone unloaded a lot of shares yesterday into a thin market which caused the bids to give way and the price to plummet. Simple as that.

You stated that NO TRIAL was needed. That is patently false.

Gary. You are poorly informed.

The FDA will require AT LEAST 1 trial. Frank in two recent interviews stated the number of patients required for trial 1 was reduced from 10 to 5, however, a trial proving safety and efficacy is STILL required.

Please don't spread misinformation.

Very well stated.

Don't invest emotionally and never with other people's money unless you are prepared to lose 100%.

I suggest averaging down.

News to me. Quite unfortunate. The FDA must have asked for changes to the clinical trial design from NVIV during their meeting. Now they'll review the changes etc. etc.

Bureaucracy.

Hopefully! The FDA is PAINFULLY slow...

NVIV is NOT applying for a new drug (NDA) so a PDUFA date is irrelevant.

They are going through the IDE application process. Read all about it here:

http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/default.htm

"Upon receipt of an IDE application, sponsors are notified in writing of the date that FDA received the original application and the IDE number assigned (Receipt of supplements and amendments are not acknowledged). An IDE application is considered approved 30 days after it has been received by FDA, unless FDA otherwise informs the sponsor prior to 30 calendar days from the date of receipt, that the IDE is approved, approved with conditions, or disapproved. In cases of disapproval, a sponsor has the opportunity to respond to the deficiencies and/or to request a regulatory hearing under 21 CFR Part 16."

Prices starting at $0.221? When did it EVER trade that low. What are you talking about?

http://bigcharts.marketwatch.com/kaavio.Webhost/charts/big.chart?nosettings=1&symb=nviv&uf=0&type=2&size=2&sid=5633708&style=320&freq=2&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=11&rand=560838097&compidx=&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1

There is resistance at the 50dMA ($2.39) and from previous support $2.40.

If a breakout occurs then we'll see $2.60 to $2.80 soon enough.

That being said we are in a LONG TERM base from $2 to $3 with big fluctuations in between and a real breakout needs to happen with solid volume pushing us past $3 to much higher levels.

Chart keeps getting better...nice bottom/base forming with a possible bullish 50 to 200dMA crossover event soon.

I've been buying KLH.V (SBOTF) in the mid 40s and someone came in today with big volume buying up shares.

Really low floater with a small market cap and very valuable product. Could go much higher.

Gary just dump your shares b/c clearly you are a weak hand.

Oh NO!!!! The SKY is FALLING!!! DUMP YOUR SHARES NOW!!!!

ABANDON SHIP!!!!

EXACTLY as I predicted on 12/23/2011:

"There will be another pullback and I'm sure you can buy your shares back again probably between $2.80 and $2.60."


Pullbacks are healthy and they happen in the BEST stocks. This weeds out the weak hands and establishes a higher base from which to move forward.

LoL, are you 15 years old? How long have you been investing because it seems to me that you got into NVIV at an incredibly good price ($1) and you've tripled your money on 1,000 shares and all I hear is doubts, complaints, annoyances, and pumping.

There will be another pullback and I'm sure you can buy your shares back again probably between $2.80 and $2.60.

If you believe in the company I suggest buy your shares and don't check the stock price until next year when the trials are complete.

Perhaps I'm being too harsh. You got some good advice from LiquidBull and others. Good luck to you.

BI Report is posted in the InVivo website. No new information but definitely the stock is gaining more and more investor awareness.

http://invivotherapeutics.com/pdf/BI%20Resesearch%20Report%20Dated%20December%2021,%202011.pdf

Gary the biggest pumper of them all asking whether or not to take profits.

From the man who when the stock spiked last time told those of us who sold @ $2.50 and bought back at $2 and below the following:

"Investors will reap the real rewards,and I am saying if you day trade this company you will get burnt I am not mad at no one go ahead and day trade you wil be sorry "

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69488946

I hope we can do better than AXK:

So much for facts and reasoning.

Thanks for your "predictions" Miss Cleo.

LoL The pumpers here are absolutely ridiculous. Less pumping more FACTS.

I've been in this stock since below a $1 and I have done my own analysis and due diligence and I do believe this is the first viable technology for SCI to be tested in humans, but let's be realistic.

First: Approval is not by any means "right around the corner". The FDA has still NOT given the go ahead for first-in-man studies. So the 1st clinical trial has yet to start.

Second: The first clinical trial will be 10 patients and will take I year of follow-up.

http://www.businesswire.com/news/home/20110707006771/en/InVivo-Therapeutics-Submits-IDE-Application-FDA-Spinal

The FDA might require another bigger trial before approval. Results could be negative?!?

Q1 2012 will be dominated by FDA approval to go ahead with the trial (this could already be reflected in the current stock price). More importantly, they need to do a 2nd round of fund raising and hopefully on good terms. If the stock can hold above $2.80 for 20 consecutive days then they can call on 13M warrants and raise $18M.

Newbies don't get suckered in by the pumpers and those who bought at $2.95 and now have buyer's remorse.

Funny the radio silence when the stock is heading down compared to the raucous cheerleading on the way up.

LoL

Buying some on weakness between $1.95 and $1.50 the next level of support.

And we've already rallied from $0.60 to $2.95 ... A LOT more than 60%.

What's your point?